8-K: Health In Tech, Inc. Faces Nasdaq Delisting Threat Due to Low Stock Price

Health In Tech, Inc. received a notification from Nasdaq regarding non-compliance with the minimum bid price requirement, potentially leading to delisting.

Summary

• Health In Tech, Inc. received a letter from Nasdaq on April 28, 2025, indicating that its Class A common stock has traded below the minimum $1.00 per share requirement for 30 consecutive business days.
• The company has been granted an initial 180-day period, until October 27, 2025, to regain compliance with Nasdaq Listing Rule 5550(a)(2).
• Compliance can be achieved if the stock price closes at $1.00 or higher for at least ten consecutive business days before the deadline.
• If the company fails to regain compliance by October 27, 2025, it may be eligible for an additional 180-day compliance period, subject to meeting other listing requirements and providing notice of intent to cure the deficiency.
• The company intends to monitor the stock price and consider available options, including a potential reverse stock split, to regain compliance.
• There is no guarantee that the company will be eligible for an additional compliance period or that Nasdaq will grant continued listing after a delisting notification.
• The company may appeal any delisting determination by Nasdaq staff.

Sentiment

Score: 3

Explanation: The sentiment is negative due to the delisting notice, indicating potential financial distress and uncertainty about the company's future.

Positives

• The company has been granted an initial 180-day period to regain compliance with Nasdaq listing rules.
• The company is considering options, including a reverse stock split, to address the deficiency.
• The company has the option to appeal any delisting determination.

Negatives

• The company's stock price has been below $1.00 for 30 consecutive business days, triggering the Nasdaq notification.
• Failure to regain compliance by October 27, 2025, could lead to delisting from The Nasdaq Capital Market.
• There is no guarantee that the company will be eligible for an additional compliance period.

Risks

• The company may not be able to increase its stock price to $1.00 or higher within the compliance period.
• The company may not meet other Nasdaq compliance standards.
• Nasdaq may not grant the company any relief from delisting.
• The company's business and financial condition could be negatively impacted by the delisting process.

Future Outlook

The company intends to monitor its stock price and consider options, including a reverse stock split, to regain compliance with Nasdaq listing requirements. The company may be eligible for an additional 180-day compliance period if it meets certain conditions.

Management Comments

• The Company intends to monitor the bid price of its Class A common stock and consider available options if its Class A common stock does not trade at a level likely to result in the Company regaining compliance with Nasdaqs minimum bid price rule by October 27, 2025.

Industry Context

Many small-cap companies face challenges in maintaining Nasdaq listing compliance, especially in volatile market conditions. Delisting can significantly impact investor confidence and access to capital.

Comparison to Industry Standards

• Other companies facing similar delisting notices often explore options such as reverse stock splits, mergers, or acquisitions to improve their stock price and market capitalization.
• Companies like Digital Ally, Inc. and Waitr Holdings Inc. have previously faced similar situations and implemented reverse stock splits to regain compliance.
• The success of these strategies varies depending on the company's underlying financial performance and market conditions.

Stakeholder Impact

• Shareholders may experience a decline in the value of their investment.
• Employees may face uncertainty about their job security.
• The company's ability to raise capital may be negatively impacted.
• The company's reputation may be damaged.

Next Steps

• The company will monitor its stock price.
• The company will consider available options, including a reverse stock split.
• The company will attempt to regain compliance with Nasdaq listing rules by October 27, 2025.
• The company may appeal any delisting determination.

Key Dates

Keywords

delisting, Nasdaq, compliance, stock price, Health In Tech, minimum bid price, reverse stock split